Latest Breaking News On - Michael spigarelli - Page 3 : comparemela.com
NA Proactive news snapshot: Nova Royalty Corp, BioPorto A/S, MedX Health Corp, PsyBio Therapeutics Corp, Sigma Lithium Corporation, Todos Medical Inc
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
NA Proactive news snapshot: Kontrol Technologies Corp, Dalrada Corporation, Arizona Silver Exploration Inc, Kainantu Resources Ltd, Nova Royalty Corp, BioPorto A/S, MedX Health Corp, PsyBio Therapeutics Corp, Sigma Lithium Corporation, Todos Medical Inc
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
NA Proactive news snapshot: Braxia Scientific Corp, Renforth Resources Inc, Fobi AI Inc, LexaGene Holdings Inc, Vuzix Corporation UPDATE
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
PsyBio Therapeutics files provisional patent for producing psilocybin with the US Patent and Trademark Office
The filing increases the company s licensed patent portfolio to four pending provisional patents and one pending non-provisional patent with the US Patent and Trademark Office The patent application was titled Optimized Methods for the Production of Psilocybin and its Intermediates or Side Products
PsyBio Therapeutics Corp (CVE:PSYB) (OTCPINK:PSYBF) said it has filed a provisional patent application with the US Patent and Trademark Office (USPTO), titled Optimized Methods for the Production of Psilocybin and its Intermediates or Side Products .
The filing increases the company s licensed patent portfolio to four pending provisional patents and one pending non-provisional patent with the USPTO, PsyBio said, as it builds a platform around bacterial-based synthesis of therapeutic tryptamines, a class of hallucinogens.